GENERATION OF TOLEROGENIC DENDRITIC CELLS UNDER THE PERSISTENT INFLAMMATION STIMULATION

Copyright © 2024 by the Shock Society..

ABSTRACT: Immunosuppression, commonly accompanied by persistent inflammation, is a key feature in the later phase of sepsis. However, the pathophysiological mechanisms underlying this phenomenon remain unclear. Dendritic cells (DCs), specifically tolerogenic DCs (tolDCs), play a crucial role in this process by regulating immune responses through inducing T cell anergy and releasing anti-inflammatory cytokines. Nevertheless, the existing cell models are inadequate for investigating tolDCs during the immunosuppressive phase of sepsis. Therefore, this study aimed to develop a novel in vitro model to generate tolDCs under chronic inflammatory conditions. We have successfully generated tolDCs by exposing them to sublethal lipopolysaccharide (LPS) for 72 h while preserving cell viability. Considering that IL-10-induced tolDCs (IL-10-tolDCs) are well-established models, we compared the immunological tolerance between LPS-tolDCs and IL-10-tolDCs. Our findings indicated that both LPS-tolDCs and IL-10-tolDCs exhibited reduced expression of maturation markers, whereas their levels of inhibitory markers were elevated. Furthermore, the immunoregulatory activities of LPS-tolDCs and IL-10-tolDCs were found to be comparable. These dysfunctions include impaired antigen presenting capacity and suppression of T cell activation, proliferation, and differentiation. Notably, compared with IL-10-tolDCs, LPS-tolDCs showed a reduced response in maturation and cytokine production upon stimulation, indicating their potential as a better model for research. Overall, in comparison with IL-10-tolDCs, our data suggest that the immunological dysfunctions shown in LPS-tolDCs could more effectively elucidate the increased susceptibility to secondary infections during sepsis. Consequently, LPS-tolDCs have emerged as promising therapeutic targets for ameliorating the immunosuppressed state in septic patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:61

Enthalten in:

Shock (Augusta, Ga.) - 61(2024), 3 vom: 01. März, Seite 454-464

Sprache:

Englisch

Beteiligte Personen:

Miao, Shumin [VerfasserIn]
Chang, Zenan [VerfasserIn]
Gu, Bin [VerfasserIn]
Jiang, Jinlong [VerfasserIn]
Pei, Fei [VerfasserIn]
Liu, Yishan [VerfasserIn]
Zhou, Yu [VerfasserIn]
Liu, Zimeng [VerfasserIn]
Si, Xiang [VerfasserIn]
Guan, Xiangdong [VerfasserIn]
Wu, Jianfeng [VerfasserIn]

Links:

Volltext

Themen:

130068-27-8
Interleukin-10
Journal Article
Lipopolysaccharides

Anmerkungen:

Date Completed 01.04.2024

Date Revised 01.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1097/SHK.0000000000002318

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36902057X